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Introduction: Sex hormones, especially estrogens, have been implicated in articular cartilage metabolism and the
pathogenesis of postmenopausal osteoarthritis. The conversion by aromatase (CYP19A1) of androstenedione into estrone
(E1) and of testosterone into 17β-estradiol (E2) plays a key role in the endogenous synthesis of estrogens in tissue.
Methods: We analyzed the expression of aromatase (CYP19A1) in immortalized C-28/I2 and T/C-28a2 chondrocytes, as
well as in cultured primary human articular chondrocytes and human articular cartilage tissue, by means of RT-PCR,
Western blotting and immunohistochemistry. By means of quantitative RT-PCR and enzyme-linked immunosorbent assay,
we also determined whether the aromatase inhibitor letrozole influences estrogen metabolism of cultured chondrocytes
in immortalized C-28/I2 chondrocytes.
Results: Aromatase mRNA was detected in both immortalized chondrocyte cell lines, in cultured primary human
chondrocytes, and in human articular cartilage tissue. By means of Western blot analysis, aromatase was detected at the
protein level in articular cartilage taken from various patients of both sexes and different ages. Cultured primary human
articular chondrocytes, C-28/I2 and T/C-28a2, and human articular cartilage tissue reacted with antibodies for aromatase.
Incubation of C-28/I2 chondrocytes with 10−11 M to 10−7 M letrozole as an aromatase inhibitor revealed significantly
increased amounts of the mRNAs of the enzyme cytochrome P4501A1 (CYP1A1), which is involved in the catagen
estrogen metabolism, and of the estrogen receptors ER-α and ER-β. Concomitantly, synthesis of estrone (E1) was
significantly downregulated after incubation with letrozole.
Conclusions: We demonstrate that human articular cartilage expresses aromatase at the mRNA and protein levels.
Blocking of estrone synthesis by the aromatase inhibitor letrozole is counteracted by an increase in ER-α and ER-β. In
addition, CYP1A1, an enzyme involved in catabolic estrogen metabolism, is upregulated. This suggests that articular
chondrocytes use ERs functionally. The role of endogenous synthesized estrogens in articular cartilage health remains
to be elucidated.Introduction
Osteoarthritis (OA) is a multifactorial disease. Current evi-
dence suggests that both mechanical and biochemical fac-
tors are involved in its progression [1]. Its incidence is
increased in men older than 30 years of age and in women
over age 50. It seems likely that women are protected from
OA before menopause. Clinical, pathological and epidemio-
logical studies have suggested that women experience OA* Correspondence: horst.claassen©medizin.uni-halle.de
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unless otherwise stated.more often after menopause than before [2] and that hor-
mones, in particular estrogens and androgens, participate
in disease outbreak [3-9].
Sex hormone receptors have been discovered on the
articular chondrocytes of various species (pig, cattle and
human) by using immunohistochemical methods [10].
Cultured primary human articular chondrocytes express
estrogen receptors ER-α and ER-β, as well as androgen
receptors, at the mRNA and protein levels [11]. How-
ever, questions arise regarding whether these ERs areLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in articular cartilage metabolism.
Aromatase (CYP19A1) is a key enzyme in the synthesis of
sex hormones and is involved in the aromatization of andro-
stenedione to form estrone (E1) and of testosterone to form
17β-estradiol (E2) (Figure 1). Estrone itself is transformed
into 17β-estradiol by the enzyme hydroxysteroid (17β) de-
hydrogenase HSD17B1 [12]. Aromatase can be inhibited
by letrozole [13]. Researchers have previously shown that
chondrocytes in the rib and tibial growth plate, as well as in
the temporomandibular joints of male and female rats, ex-
press aromatase at the mRNA and protein levels, a process
required for the production of 17β-estradiol [14]. Endogen-
ous estrogen synthesis has been detected in temporoman-
dibular joint chondrocytes [15] and in the human cartilage
cell line HCS-2/8 [16]. In human articular cartilage, aroma-
tase was first detected by immunohistochemistry [17].
In the present study, we analyzed whether cultured pri-
mary human articular chondrocytes and immortalized
chondrocytes of the cell lines C-28/I2 and T/C-28a2 (iso-
lated from rib cartilage) express the enzyme aromatase at
the mRNA and protein levels. In cultured chondrocytes, we
studied whether enzymes involved in estrogen metabolism,
such as cytochrome P4501A1 (CYP1A1) are influenced by
aromatase inhibition with letrozole, followed by blocked
synthesis of E1 and E2 estrogens. A further objective of the
study was to investigate the influence of letrozole with re-
gard to the expression of ER-α and ER-β on mRNA levels.
A future goal of ours is to analyze the role of endogenous
estrogens for articular cartilage health with regard to
menopausal OA.Figure 1 Schematic showing the details of the estrogen pathway. And
17β-estradiol (E2) by aromatase, also named CYP19A1, as the key enzyme
resulting in blocked synthesis of the estrogens E1 and E2. By contrast, cyt
catabolism, converts estrone into the hydroxylated catechol estrogen 2-O
4-OH-E2: 4-hydroxyestradiol; COMT: Catechol-O-methyltransferase; DHEA:
hydroxysteroid 3β-dehydrogenase 1. The diagram is modified from a figuMethods
Human tissue
The patients provided their informed consent to partici-
pate in the project prior to surgery. The study was ap-
proved by the Institutional Review Board of Martin Luther
University Halle-Wittenberg and was carried out in ac-
cordance with the Declaration of Helsinki.Chondrocyte culture
For isolation of primary human articular chondrocytes, ar-
ticular cartilage was obtained from the posterior area of
the medial and lateral femoral condyles of two female pa-
tients, ages 70 and 71 years, respectively, who underwent
total knee replacement in the Department of Orthopedics
at Martin Luther University Halle-Wittenberg. To prepare
chondrocytes for cell cultures, full-thickness cartilage taken
from patient biopsies was used. The available amount of
primary chondrocytes was too restricted to perform exten-
sive cell culture experiments, so we chose to examine the
chondrocyte cell lines C-28/I2 and T/C-28a2. The immor-
talized chondrocyte cell lines C-28/I2 and T/C-28a2, which
originated from cells isolated from rib cartilage of a 15-
year-old female, were transduced with simian virus 40 con-
taining the large T antigen [18]. Both cell lines express
SOX9 as the master gene of chondrocytic cell differenti-
ation. The major difficulty with studying C-28/I2 and T/C-
28a2 chondrocytes is that they mainly proliferate and show
less expression of genes of matrix synthesis and turnover
[19,20]. However, C-28/I2 chondrocytes express significantly
higher levels of matrix-degrading proteases compared withrostenedione and testosterone are converted to estrone (E1) and
of estrogen biosynthesis. Aromatase can be inhibited by letrozole,
ochrome P4501A1 (CYP1A1), as an enzyme involved in estrogen
H-E1. 2-OH-E2: 2-hydroxyestradiol; 4-OH-E1: 4-hydroxyestrone;
Dehydroepiandrosterone; ER: Estrogen receptor; HSD3B1:
re published previously by Dumas and Diorio [12].
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formed as described previously [11].
Incubation with letrozole
At the end of culture with serum, C-28/I2 and T/C-28a2
chondrocytes were changed to serum-free medium for
2 hours, cells were incubated alone or with a range of con-
centrations (10−11 M, 10−9 M and 10−7 M) of letrozole
(Femara; Novartis Oncology, Nuremberg, Germany) dur-
ing the two serum-free days (days 6 and 7 or days 8 and 9,
respectively). For this purpose, stock solutions of 10−1 M
letrozole (EtOH-soluble) were prepared and dissolved
stepwise with distilled H2O (EMD Millipore, Billerica,
MA, USA). All experiments were performed in triplicate,
and controls were incubated with water instead of the aro-
matase inhibitor letrozole.
Human tissues
Articular cartilage samples were obtained from autopsy
cases (9 males: ages 22, 24, 28, 33, 41, 48, 59, 66 and
73 years; 7 females: ages 3, 7, 38, 52, 62, 83 and 90 years)
from the Institute of Legal Medicine, Charité-University
Medicine Berlin, Germany. Samples used for positive con-
trols, such as placenta, testicle, ovary, lung, lacrimal gland,
heart, uterus, prostate and nasal turbinate epithelium,
were obtained from cadavers donated to the Department
of Anatomy and Cell Biology, Martin Luther University
Halle-Wittenberg, Germany.
Reverse transcription
Total RNA from cultured C-28/I2 and T/C-28a2 chon-
drocytes, from primary human articular chondrocytes
and from human ovary were isolated as described pre-
viously [11].
Quantitative RT-PCR
Samples from cultured C-28/I2 chondrocytes were ana-
lyzed using the StepOnePlus Real-Time PCR System
(Applied Biosystems, Foster City, CA, USA). Real-time
RT-PCR was performed with specific primers (Table 1) to
allow calculation of the relative abundance of transcripts.
The reactions were performed using 10 μl of SYBR Green
Master Mix (MESA BLUE qPCR MasterMix Plus for
SYBR Assay; Eurogentec, Cologne, Germany) and 3 μl ofTable 1 Sequences of the primers used for RT-PCR and real-ti
Primer Sense primers (5′→ 3′) Ant
Aromatase CGA GAT CGA AAT TCT GGT GGA AAA G TGC
CYP1A1 CCT CTT TGG AGC TGG GTT TG GCT
ERα CAA TGA CTA TGC TTC AGG CTAC CCA
ERβ GAG TCC CTG GTG TGA AGC AA TGA
β-actin CAA GAG ATG GCC ACG GCT GCT TCC
aCYP1A1: Cytochrome P4501A1; ER: Estrogen receptor.cDNA. The cycle parameters were 5 minutes at 95°C
and 40 three-step cycles of 10 seconds at 95°C, 15 sec-
onds at 60°C and 20 seconds 72°C. Standard curves
were generated for each gene using a plasmid dilution
series containing the target sequences. All quantitative
RT-PCRs (qRT-PCRs) were performed in triplicate,
and the changes in gene expression were calculated by
the 2-ΔΔCt relative quantitation method. Analysis
of the data yielded values relative to the mRNA
concentration.
Protein preparation
Protein was isolated as described previously [11].
Western blot analysis
For each articular cartilage sample and each positive
control sample (see Human tissue), 20 μg protein/lane
were prepared under conditions as described previously
[11] and incubated with specific antibodies for aromatase
(Acris, SM2222P) at 4°C overnight.
Immunohistology and immunocytochemistry with
peroxidase
Human articular cartilage from 28 and 83-year-old male
donors were dehydrated and embedded in paraffin. Sec-
tions of 3-5 μm were deparaffinized and stained with
specific antibody for aromatase (SM2222P; Acris Anti-
bodies, Herford, Germany) at 4°C overnight. The proto-
col followed was described previously [11].Immunocytochemistry with fluorescein isothiocyanate
Immortalized chondrocytes of the cell lines C-28/I2 and
T/C-28a2 or primary human articular chondrocytes cul-
tured on glass coverslips were prepared under conditions
described previously [11] and incubated with specific
antibodies for aromatase (SM2222P; Acris Antibodies)
at 4°C overnight. Immunoreactions were analyzed
using a fluorescence microscope (BZ-8100; Keyence
Deutschland GmbH, Frankfurt, Germany). Double-
staining was performed based on the same principle.
The second antibody used was goat anti-rabbit calreti-
culin (ABR-01176; Dianova, Hamburg, Germany) as a
marker of endoplasmic reticulum.me analysisa
isense primers (5′→ 3′) Base pair Temperature
AAA ATC CAT ACA GTC TT 177 60°C
GTG GGG GAT GGT GAA 229 60°C
CCT TTC ATC ATT CCC AC 198 60°C
GCA TCC CTC TTT GAA CC 199 60°C
TTC TGC ATC CTG TCG GCA 275 60°C
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A commercially available enzyme-linked immunosorbent
assay (ELISA) kit (DRG Instruments, Marburg, Germany)
was used manufacturer instruction to quantify the amount
of estrone (EIA-4174) in supernatants from stimulated C-
28/I2 cells. The analysis was performed using a microplate
spectrophotometer (ELISA reader) to measure absorbance
(450 nm). The concentrations of the samples are expressed
in picograms per milliliter.
Statistics
The data are expressed as the mean ± standard error of
the mean (SEM) of tested samples. Statistical analysis was
performed using the Mann-Whitney U test or analysis of
variance after assessing the normal distribution of the data
using InStat statistical software (GraphPad Software, San
Diego, CA, USA). P-values ≤0.05 were considered statisti-
cally significant.
Results
Expression of aromatase at mRNA level
With specific primers for human aromatase (CYP19A1), a
PCR product of the expected size (177 bp) was found in all
samples of cultured primary human articular chondrocytes,
cultured C-28/I2 and T/C-28a2 chondrocytes, as well as in
samples of human articular cartilage tissue (Figure 2A). Se-
quencing of the bands showed 100% agreement with the
corresponding human DNA sequence.
Expression of aromatase at protein level
Western blot analysis for aromatase revealed that articular
cartilage in all samples taken from both sexes and different
ages expressed the enzymes at the expected molecular
weight (55 kDa) (Figure 2B). The expression pattern of the
enzymes, in comparison with β-actin, did not depend on
sex or age. Both sexes showed stronger expression of the
enzyme aromatase, beginning in the seventh decade of life,
compared with younger participants. Furthermore, aroma-
tase was detected in placenta, testis, ovary, uterus, prostate
and in primary non-sex-hormone–dependent organs such
as lung, lacrimal gland, heart and nasal turbinate epithe-
lium (Figure 2C).
Immunocytochemistry and immunohistochemistry
The cytoplasm of cultured primary human articular chon-
drocytes and cultured, immortalized C-28/I2 chondrocytes
were immunostained by a specific antibody for aromatase
(Figures 3A, 3B and 3D). Cells of the immortalized chon-
drocyte cell line T/C-28a2 showed an identical staining pat-
tern (not shown). Additionally, chondrocytes of all articular
cartilage samples reacted with the antibody to aromatase
(Figure 3C). However, a zone-dependent expression of this
enzyme was not observed. Exact localization of the en-
zyme by immunocytochemical staining of nuclei by 4′,6-diamidino-2-phenylindole and the aromatase reactivity by
antibody SM2222P were analyzed using laser scanning mi-
croscopy (Figure 3E). Positive reactivity was visible only as
a small rim of cytoplasm around the nucleus of immortal-
ized chondrocytes C-28/I2 and T/C-28a2 with antibodies
for aromatase. Aromatase showed expression on endo-
plasmic reticulum. Double staining with antibodies for
aromatase and calreticulin as markers for endoplasmic
reticulum revealed partial overlap of the staining patterns
for both proteins (Figure 3E). In primary human articular
cartilage chondrocytes from tissue with and without OA
aromatase is equally expressed in all cells (Figure 3F).
Letrozole incubation of C-28/I2 chondrocytes
To test the influence of the aromatase inhibitor letro-
zole on the expression of the catabolic enzyme cyto-
chrome P4501A1 (CYP1A1) and ER-α and ER-β, C-28/
I2 chondrocytes were incubated with different concen-
trations of 10−11 M - 10−7 M letrozole for 12, 24 and
48 hours. qRT-PCR analysis revealed statistically signifi-
cant increased mRNA expression of CYP1A1 after incu-
bation with 10−7 M letrozole for 48 hours compared to
control (Figure 4A), whereas, after 12 and 24 hours, no
increased expression of CYP1A mRNA could be de-
tected. Also, incubation with 10−11 M - 10−9 M letrozole
showed no effect on CYP1A1 mRNA expression. ER-β
mRNA was significantly increased after 48-hour incubation
with 10−11 M to 10−7 M letrozole (Figure 4B), whereas, after
12 and 24 hours of incubation, no effect was observed. Fur-
thermore, ER-α mRNA was significantly increased after in-
cubation with 10−11 M to 10−7 M letrozole for 24 and
48 hours (Figure 4C). Incubation for 12 hours showed no
significant influence on the expression of ER-α mRNA. The
concentration of estrone (E1) in articular chondrocytes was
quantified by means of ELISA. In comparison to controls, a
statistically significant downregulation of this hormone was
observed after incubation with 10−11 M to 10−7 M letrozole
for 48 hours (Figure 4D). Incubations for 12 or 24 hours
showed no effect on the concentration of estrone.
Discussion
High estradiol levels in late puberty induce growth plate
closure and thus cessation of growth in humans [21]. The
enzyme aromatase (CYP19A1), which converts androstene-
dione into 17β-estradiol, is expressed in the hypertrophic
zone of human growth plates [22]. These facts are consist-
ent with a role for local estrogen production in the para-
crine control of long-bone growth. On the basis of studies
of patients with a mutated aromatase gene or defective ER-
α, it has become clear that the action of estrogen is indis-
pensable for normal pubertal growth [23,24]. Inhibition of
estrogen action by aromatase inhibitors such as letrozole
seems to decelerate the process of growth plate fusion
[13]. Therefore, letrozole can be used therapeutically to
Figure 2 Detection of aromatase in human articular cartilage tissue, in primary human articular chondrocytes and in chondrocyte cell
lines C-28/I2 and T/C-28a2. (A) Aromatase mRNA (177 bp) was detected in articular cartilage tissue (lane 1), in cultured articular chondrocytes
(lane 2) and in immortalized chondrocytes of cell lines C-28/I2 (lane 3) and T/C-28a2 (lane 4). Diethylpyrocarbonate water served as a negative
control (lane 5). (B) Western blot analysis of aromatase using the antibody SM2222P in articular cartilage tissue from patients of both sexes and
different ages. Aromatase protein is detected at 55 kDa in articular cartilage from females ages 3, 7, 38, 52, 62 and 83 years and from men at ages
22, 24, 28, 33, 41, 48, 59, 66 and 73 years. (C) Western blot analysis of aromatase in various control tissues. Aromatase protein is found in both
primary sex hormone–dependent organs, such as placenta (lane 1), testicle (lane 2), ovary (lane 3), uterus (lane 7) and prostate (lane 8), and in
primary non-sex-hormone–dependent organs, such as lung (lane 4), lacrimal gland (lane 5), heart (lane 6) and nasal turbinate epithelium (lane 9).
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short stature [25]. Compared to controls, the height of the
epiphyseal growth plate is increased by 12% in letrozole-
treated mice [26].
Locally synthesized 17β-estradiol is useful for growth
plate chondrocytes of the cell line HCS-2/8 because it stim-
ulates proliferation and protects against spontaneous apop-
tosis [16]. On the basis of the clinical observation that
women suffer more from OA with the beginning of meno-
pause [1], it can be asked whether estrogens play a role in
this disease and, in particular, if endogenously produced es-
trogens are protective of articular cartilage. In postmeno-
pausal women, estradiol is produced at extragonadal sites
such as in cells of adipose tissue and in numerous sites of
the brain acting as paracrine factors [27,28]. Articular chon-
drocytes of rats are capable of synthesizing sex steroid hor-
mones locally from dehydroepiandrosterone (DHEA) [29].
In our present study, we detected aromatase in cultured
primary human articular chondrocytes and in immortal-
ized chondrocytes of cell lines C-28/I2 and T/C-28a2 at
the mRNA and protein levels. Both cell lines originated
from chondrocytes isolated from the rib cartilage of a 15-
year-old female [18]. Because ERs were found in cell lines
C-28/I2 and T/C-28a2 originating from rib cartilage [11],
it is not surprising that both chondrocytes of rib cartilage
and chondrocytes of articular cartilage express the enzymearomatase. In relation to the housekeeping gene β-actin,
at the mRNA level, aromatase is expressed more strongly
in the immortalized cell lines C-28/I2 and T/C-28a2 com-
pared to articular cartilage tissue and cultured primary ar-
ticular chondrocytes (Figure 2A). However, immortalized
chondrocytes from rib cartilage may differ from primary
articular chondrocytes with regard to the strength of pro-
tein expression [30]. As stated by Finger and colleagues
[19], the expression of SOX9 as a marker gene of chondro-
cyte differentiation is at a significant level in both cell
lines, whereas extracellular matrix proteins and matrix-
degrading proteases are rarely expressed. In addition, it
must be taken into account that primary articular chon-
drocytes were derived from endoprosthesis surgery in two
women, ages 70 and 71 years, respectively, who had OA of
the knee (see the Methods section). Because aromatase
supplies articular cartilage, with endogenous estrogens hy-
pothesized to be cartilage-protective, the weaker expres-
sion of this enzyme may be induced by OA. At the protein
level, the observed expression of aromatase is not sex-
specific when age-matched females and males are com-
pared (Figure 2B). Compared to females and males ages 2
to 59 years, aromatase expression in both sexes is stronger
beginning at 60 years of age. Perhaps the stronger expres-
sion of aromatase as an enzyme-converting androstene-
dione in estrogens reflects a lack of endogenous estrogens
Figure 3 Immunocytochemical and immunohistochemical staining of aromatase or aromatase combined with calreticulin in human
articular cartilage tissue, in primary human articular chondrocytes and in immortalized chondrocytes of cell line C-28/I2. (A) Cultured
primary articular chondrocytes react with aromatase antibody as revealed by red staining. (B) Cultured chondrocytes of cell line C-28/I2 react with
the aromatase antibody. Control cells do not react. (C) Articular cartilage tissue shows immunoreactivity for aromatase, and the control remains
unstained. (D) Localization of aromatase by immunofluorescence. The slides present staining of nuclei by 4′,6-diamidino-2-phenylindole (DAPI)
and of cytoplasm with fluorescein isothiocyanate (FITC)–conjugated antibodies to aromatase (antibody) or combined staining of nuclei and
aromatase (merged image). Cytoplasm of cultured C-28/I2 cells show positive reaction for aromatase. (E) Localization of aromatase combined with
calreticulin by immunofluorescence. The slides present staining of nuclei by DAPI; staining of cytoplasm with FITC-conjugated secondary
antibodies against aromatase or calreticulin; and combined staining of nuclei, aromatase and calreticulin (merged image). As shown by single-cell
laser-scanning microscopy, staining for aromatase and calreticulin is observed at approximately identical cytoplasmic sites. ER: Endoplasmic
reticulum. (F) Primary human articular chondrocytes from knee joint tissue with and without osteoarthritis (OA) show aromatase immunostaining
equally in all chondrocytes. Scale bars: 50 μm (A and B), 10 μm (C and E) and 20μm (F).
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ages. In human bone tissue, the amount of aromatase
mRNA expression was found to correlate positively with
the degree of osteoporotic changes [17]. Taken together,
analogously to bone tissue, endogenous estrogens mightbe cartilage-protective for both sexes at advanced ages.
Unfortunately, this hypothesis does not explain the clinical
observation that women are generally protected against
OA until menopause, but men can be affected beginning
in approximately the fourth decade of life.
Figure 4 Influence of letrozole on mRNA concentrations of cytochrome P4501A1 and estrogen receptors ER-α and ER-β in cultured
C-28/I2 chondrocytes analyzed by quantitative RT-PCR and on estrone concentration of these cells assessed by enzyme-linked immunosorbent
assay. (A) Compared to controls, chondrocytes cultured without aromatase inhibitor incubated with 10−11 M to 10−7 M letrozole show
significantly increased expression of cytochrome P4501A1 (CYP1A1) mRNA after 48 hours with 10−7 M letrozole. We also observed a tendency
toward this effect after incubation for 12 and 24 hours using concentrations of 10−9 M and 10−7 M letrozole. (B) Quantitative RT-PCR (qRT-PCR)
shows significantly increased expression of estrogen receptor ER-β mRNA following incubation with 10−11 M to 10−7 M letrozole for 48 hours. No
regulatory influence was observed after incubation with 10−11 M to 10−7 M letrozole for 12 and 24 hours. (C) qRT-PCR revealed significantly
increased expression of ER-α mRNA following incubation with 10−7 M and 10−11 M letrozole for 24 and 48 hours. (D) In comparison to control
chondrocytes cultured without aromatase inhibitor, incubation with 10−11 M to 10−7 M letrozole for 48 hours led to significantly downregulated
expression of estrone (E1) protein as revealed by enzyme-linked immunosorbent assay. All experiments were performed in triplicates (n = 3).
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in the cytoplasm of the cell lines studied. Additionally, a
predominant localization of aromatase near the endo-
plasmic reticulum was shown by double-staining with
antibodies to aromatase and calreticulin. Aromatase was
previously found to be undetectable in rabbit articular
cartilage [31]. However, Bellino detected another enzyme
specific for estrogen metabolism: 17β-hydroxysteroid de-
hydrogenase. Because aromatase is produced in human
articular chondrocytes, we speculate that these cells can
synthesize 17β-estradiol and that endogenous estrogens
play a role in articular cartilage health. This hypothesis
is confirmed by experiments with DHEA-treated chon-
drocytes where the aromatase inhibitor letrozole locally
reduced estrogen synthesis followed by increased expres-
sion of matrix metalloproteinase 13 and decreased syn-
thesis of type II collagen [32]. Both effects are damaging
to the articular cartilage matrix. Furthermore, letrozole
used for treatment of early postmenopausal breast can-
cer has been reported to induce arthralgia [33]. By con-
trast, it has been speculated that aromatase plays animportant role in the development of temporomandibu-
lar joint disorders by producing estrogens [14].
As for OA, endogenous estradiol is assumed to play a
role in bone health and has been discussed with regard to
its involvement in bone fractures [34]. A novel mutation
of the human aromatase gene was shown to be involved in
bone growth and mineralization [35]. Estrogen deprivation
was established as a central mechanism in the develop-
ment of osteoporosis with aging [36]. In postmenopausal
women on dialysis, who have a high risk for developing
mineral and bone disorders, it was shown that endogen-
ous estrogens may prevent bone loss [37].
Furthermore, we asked what happens in articular cartil-
age metabolism when estrogen synthesis is blocked by the
aromatase inhibitor letrozole (Figure 1A). Following incu-
bation of C-28/I2 chondrocytes with 10−11 M to 10−7 M
letrozole for 48 hours, CYP1A1 mRNA was significantly in-
creased compared to controls. The enzyme CYP1A1 partic-
ipates in estrogen catabolism and causes 2-hydroxylation of
estrone (E1) [12,38]. Concomitantly, mRNA expression of
ER-α and ER-β was significantly increased. We hypothesize
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estrogens in their vicinity, thereby increasing the amounts
of their ERs. The accumulation of the catabolic enzyme
CYP1A1 may be interpreted as an attempt by the chondro-
cytes to hydroxylate existing remnants of estrone to cat-
echol estrogens.
Serum concentrations of free and total estradiol, as
well as of estrogen metabolites such as 2-hydroxyestrone
(2-OH-E1), 2-hydroxyestradiol (2-OH-E2) and 16α-
hydroxyestrone, have been shown to be involved in female
OA [39] (Figure 1). Gao and colleagues [39] showed that
free and total estradiol are reduced, but the total 2-OH-E2
level was increased, in postmenopausal women. In addition,
it should be noted that total 2-OH-E1 concentration is posi-
tively correlated with the total estradiol level in premeno-
pausal women with OA. Afzal and Khanam [40] observed
high levels of the proinflammatory cytokine interleukin 6 ac-
companied by decreased estrogen levels in postmenopausal
female OA patients. From another point of view, it was
stated that estrogens reduce cellular aging in chondrocytes
by deceleration of telomere attrition [41].
Taken together, articular chondrocytes of both sexes
possess the enzyme aromatase, also named CYP19A1, at
the mRNA and protein levels. Chondrocytes tend to in-
crease their amounts of ER-α and ER-β when estrone
synthesis is blocked by the aromatase inhibitor letrozole.
Furthermore, the catabolic enzyme CYP1A1, which hy-
droxylates estrone, is increased after blocking of estrone
synthesis with letrozole.
Conclusion
We conclude that chondrocytes react with a change in the
expression of their ERs following intervention in the ana-
bolic pathway of estrogen synthesis (Figure 1). The results
presented herein reveal that human articular cartilage ex-
presses the enzyme aromatase (in mRNA and protein).
The results also suggest that articular chondrocytes are
able to produce estrogens by themselves and are inde-
pendent of external estrogen metabolism. Furthermore,
articular chondrocytes use ER-α and ER-β functionally.
The influence of estrogens on cartilage metabolism has
been shown in several recent studies, which reflects the
complexity of negative and positive effects of sex hor-
mones on articular cartilage metabolism. Further investi-
gations are needed to elucidate the special pathways and
functions of estrogens, especially endogenous synthesized
estrogens, in articular cartilage metabolism with regard to
menopausal OA.
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